Ha habido 50 transacciones internas recientes registradas para TCR2 Therapeutics Inc. (TCRR), incluyendo 20 compras y 29 ventas. El total de compras internas fue valorado en $747.5K y el total de ventas internas en $1.8M.
Internos destacados con actividad reciente incluyen Tang Kevin C, Allen Andrew R, Webster Stephen W. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — TCRR
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2023-06-01 |
Tang Kevin C |
10 Percent Owner |
Otro (Venta) |
4,394,800 |
- |
- |
- |
| 2023-06-01 |
Allen Andrew R |
Director |
Devolución de Acciones |
8,072 |
$6.07 |
$49K |
- |
| 2023-06-01 |
Webster Stephen W |
Director |
Devolución de Acciones |
10,482 |
$9.54 |
$100K |
- |
| 2023-06-01 |
Gibson Neil W |
Director |
Devolución de Acciones |
8,072 |
$6.07 |
$49K |
- |
| 2023-06-01 |
Menzel Garry E |
President and CEO |
Devolución de Acciones |
39,681 |
- |
- |
- |
| 2023-06-01 |
Sullivan Eric |
Chief Financial Officer |
Devolución de Acciones |
6,804 |
- |
- |
- |
| 2023-06-01 |
Tomasello Shawn |
Director |
Devolución de Acciones |
4,177 |
$26.33 |
$109.98K |
- |
| 2023-06-01 |
Justice Angela |
Chief People Officer |
Devolución de Acciones |
6,336 |
- |
- |
- |
| 2023-06-01 |
Cardama Alfonso Quintas |
Chief Medical Officer |
Devolución de Acciones |
9,549 |
- |
- |
- |
| 2023-06-01 |
Hoos Axel |
Director |
Devolución de Acciones |
12,100 |
$5.21 |
$63.04K |
- |
| 2023-06-01 |
Harrison Rosemary |
Chief Business & Strategy |
Devolución de Acciones |
191,102 |
$4.04 |
$772.05K |
- |
| 2023-06-01 |
Olagunju Peter |
Chief Operating Officer |
Devolución de Acciones |
62,047 |
- |
- |
- |
| 2023-06-01 |
Hegde Priti |
Director |
Devolución de Acciones |
24,968 |
$16.02 |
$399.99K |
- |
| 2023-06-01 |
Gadicke Ansbert |
10 Percent Owner |
Otro (Venta) |
3,370,982 |
- |
- |
- |
| 2023-06-01 |
Mpm Bioventures 2014, L.p. |
10 Percent Owner |
Otro (Venta) |
4,158,964 |
- |
- |
- |
| 2023-06-01 |
Ubs Oncology Impact Fund L.p. |
10 Percent Owner |
Otro (Venta) |
3,370,982 |
- |
- |
- |
| 2023-06-01 |
Mpm Sunstates Fund, L.p. |
10 Percent Owner |
Otro (Venta) |
4,158,964 |
- |
- |
- |
| 2023-05-25 |
Tang Kevin C |
10 Percent Owner |
Compra Informativa |
50,000 |
$1.72 |
$86K |
4,394,800 |
| 2023-05-22 |
Gadicke Ansbert |
10 Percent Owner |
Ejercicio de Opciones (ITM) |
135,508 |
$0.74 |
$100.28K |
- |
| 2023-05-22 |
Mpm Asset Management Llc |
10 Percent Owner |
Ejercicio de Opciones (ITM) |
135,508 |
$0.74 |
$100.28K |
- |
| 2023-05-12 |
Tang Kevin C |
10 Percent Owner |
Compra Informativa |
6,183 |
$1.95 |
$12.06K |
4,344,800 |
| 2023-05-11 |
Tang Kevin C |
10 Percent Owner |
Compra Informativa |
38,765 |
$1.95 |
$75.59K |
4,338,617 |
| 2023-05-10 |
Tang Kevin C |
10 Percent Owner |
Compra Informativa |
6,774 |
$1.95 |
$13.21K |
4,299,852 |
| 2023-05-09 |
Tang Kevin C |
10 Percent Owner |
Compra Informativa |
20,141 |
$1.95 |
$39.27K |
4,293,078 |
| 2023-05-08 |
Tang Kevin C |
10 Percent Owner |
Compra Informativa |
57,073 |
$1.95 |
$111.29K |
4,272,937 |
| 2023-05-05 |
Tang Kevin C |
10 Percent Owner |
Compra Informativa |
95,759 |
$1.90 |
$181.94K |
4,144,800 |
| 2023-05-04 |
Tang Kevin C |
10 Percent Owner |
Compra Informativa |
104,241 |
$1.86 |
$193.89K |
4,049,041 |
| 2023-05-03 |
Tang Kevin C |
10 Percent Owner |
Desconocido |
- |
- |
- |
3,926,287 |
| 2023-05-03 |
Tang Kevin C |
10 Percent Owner |
Compra Informativa |
18,513 |
$1.85 |
$34.25K |
3,944,800 |
| 2022-12-15 |
Allen Andrew R |
Director |
Concesión de RSU |
16,800 |
- |
- |
16,800 |
| 2022-12-15 |
Webster Stephen W |
Director |
Concesión de RSU |
16,800 |
- |
- |
16,800 |
| 2022-12-15 |
Menzel Garry E |
President and CEO |
Concesión de RSU |
39,681 |
- |
- |
39,681 |
| 2022-12-15 |
Sullivan Eric |
Chief Financial Officer |
Concesión de RSU |
6,804 |
- |
- |
6,804 |
| 2022-12-15 |
Tomasello Shawn |
Director |
Concesión de RSU |
16,800 |
- |
- |
16,800 |
| 2022-12-15 |
Justice Angela |
Chief People Officer |
Concesión de RSU |
13,083 |
- |
- |
13,083 |
| 2022-12-15 |
Cardama Alfonso Quintas |
Chief Medical Officer |
Concesión de RSU |
11,775 |
- |
- |
11,775 |
| 2022-12-15 |
Hoos Axel |
Director |
Concesión de RSU |
16,800 |
- |
- |
16,800 |
| 2022-12-15 |
Harrison Rosemary |
Chief Business & Strategy |
Concesión de RSU |
12,822 |
- |
- |
12,822 |
| 2022-12-15 |
Olagunju Peter |
Chief Technical Officer |
Concesión de RSU |
16,354 |
- |
- |
16,354 |
| 2022-12-15 |
Hegde Priti |
Director |
Concesión de RSU |
16,800 |
- |
- |
16,800 |
| 2022-12-13 |
Menzel Garry E |
President and CEO |
Venta Informativa |
11,000 |
$1.06 |
$11.68K |
138,871 |
| 2022-12-13 |
Cardama Alfonso Quintas |
Chief Medical Officer |
Venta Informativa |
4,752 |
$1.06 |
$5.04K |
109,459 |
| 2022-12-13 |
Olagunju Peter |
Chief Technical Officer |
Venta Informativa |
1,659 |
$1.07 |
$1.77K |
24,092 |
| 2022-12-12 |
Menzel Garry E |
President and CEO |
Venta Informativa |
10,613 |
$1.10 |
$11.67K |
149,871 |
| 2022-12-12 |
Justice Angela |
Chief People Officer |
Venta Informativa |
2,963 |
$1.06 |
$3.15K |
48,745 |
| 2022-12-12 |
Cardama Alfonso Quintas |
Chief Medical Officer |
Venta Informativa |
4,586 |
$1.10 |
$5.04K |
114,211 |
| 2022-12-12 |
Olagunju Peter |
Chief Technical Officer |
Venta Informativa |
1,610 |
$1.10 |
$1.77K |
25,751 |
| 2022-12-09 |
Menzel Garry E |
President and CEO |
Venta Informativa |
10,325 |
$1.13 |
$11.68K |
160,484 |
| 2022-12-09 |
Justice Angela |
Chief People Officer |
Venta Informativa |
2,792 |
$1.13 |
$3.15K |
54,573 |
| 2022-12-09 |
Cardama Alfonso Quintas |
Chief Medical Officer |
Venta Informativa |
4,461 |
$1.13 |
$5.04K |
118,797 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
